Breaking News Instant updates and real-time market news.

SGEN

Seattle Genetics

$120.28 /

-0.74 (-0.61%)

, ALPMY

Astellas Pharma

$0.00 /

+ (+0.00%)

08:13
12/02/19
12/02
08:13
12/02/19
08:13

Seattle Genetics, Astellas Pharma announce trial collaboration with Merck

Seattle Genetics (SGEN) and Astellas Pharma (ALPMY) announced a clinical collaboration agreement with Merck (MRK), through a subsidiary, to evaluate the combination of Seattle Genetics' and Astellas' antibody-drug conjugate enfortumab vedotin and Merck's anti-PD-1 therapy, KEYTRUDA, in patients with previously untreated metastatic urothelial cancer. Under the terms of the agreement, the three companies will conduct and fund a global, registrational phase 3 clinical trial to be led by Seattle Genetics. The trial will be designed to evaluate the efficacy of the combination of enfortumab vedotin and pembrolizumab in patients with previously untreated locally advanced or metastatic urothelial cancer. The companies are working in consultation with regulatory authorities to finalize the trial design and currently plan to initiate the trial in the first half of 2020.

SGEN

Seattle Genetics

$120.28 /

-0.74 (-0.61%)

ALPMY

Astellas Pharma

$0.00 /

+ (+0.00%)

MRK

Merck

$87.10 /

-0.52 (-0.59%)

  • 04

    Dec

  • 07

    Dec

  • 10

    Dec

  • 11

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

  • 15

    Mar

SGEN Seattle Genetics
$120.28 /

-0.74 (-0.61%)

10/22/19 OPCO
Seattle Genetics price target raised to $110 from $92 at Oppenheimer
10/22/19 RBCM
Seattle Genetics price target raised to $109 from $80 at RBC Capital
10/22/19 LEER
Seattle Genetics price target raised to $120 from $102 at SVB Leerink
10/29/19 PIPR
Seattle Genetics price target raised to $120 from $95 at Piper Jaffray
ALPMY Astellas Pharma
$0.00 /

+ (+0.00%)

09/24/19 JEFF
Astellas Pharma initiated with a Buy at Jefferies
MRK Merck
$87.10 /

-0.52 (-0.59%)

10/17/19 BOFA
Vertex added to US 1 List, Merck, Ferrari removed at BofA/Merrill
10/18/19 MZHO
Merck's Keytruda pulling farther ahead of competition, says Mizuho
10/30/19 MZHO
Merck price target raised to $100 from $97 at Mizuho
11/08/19 LEER
Merck data a 'much needed positive' for Aduro Biotech, says SVB Leerink

TODAY'S FREE FLY STORIES

Periodicals
Egypt signs two Mediterranean deals with Exxon Mobil, Reuters reports » 12:17
01/28/20
01/28
12:17
01/28/20
12:17
XOM

Exxon Mobil

$64.97 /

+0.24 (+0.37%)

According to an earlier…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Technical Analysis
NASDAQ market internals summary » 12:17
01/28/20
01/28
12:17
01/28/20
12:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Technical Analysis
NYSE market internals summary » 12:16
01/28/20
01/28
12:16
01/28/20
12:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is average for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
K12 price target lowered to $30 from $40 at Barrington » 12:15
01/28/20
01/28
12:15
01/28/20
12:15
LRN

K12

$16.39 /

-3.19 (-16.29%)

Barrington analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Inogen management to meet with William Blair » 12:07
01/28/20
01/28
12:07
01/28/20
12:07
INGN

Inogen

$45.97 /

-0.41 (-0.88%)

Meeting to be held in New…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Jeld-Wen share price weakness providing attractive entry point, says Jefferies » 12:07
01/28/20
01/28
12:07
01/28/20
12:07
JELD

Jeld-Wen

$24.75 /

-1.37 (-5.25%)

, HD

Home Depot

$234.60 /

+3.355 (+1.45%)

Jefferies analyst Philip…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Tupperware Brands falls -8.4% » 12:00
01/28/20
01/28
12:00
01/28/20
12:00
TUP

Tupperware Brands

$7.02 /

-0.63 (-8.24%)

Tupperware Brands is down…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Aspen Aerogels falls -10.4% » 12:00
01/28/20
01/28
12:00
01/28/20
12:00
ASPN

Aspen Aerogels

$8.94 /

-0.95 (-9.61%)

Aspen Aerogels is down…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
K12 falls -11.1% » 12:00
01/28/20
01/28
12:00
01/28/20
12:00
LRN

K12

$17.40 /

-2.18 (-11.13%)

K12 is down -11.1%, or…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Despegar.com rises 11.5% » 12:00
01/28/20
01/28
12:00
01/28/20
12:00
DESP

Despegar.com

$13.80 /

+1.35 (+10.84%)

Despegar.com is up 11.5%,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
Hot Stocks
Novavax awarded U.S. patent for highly efficient influenza matrix proteins » 12:00
01/28/20
01/28
12:00
01/28/20
12:00
NVAX

Novavax

$7.17 /

-1.33 (-15.65%)

The USPTO website lists a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Leaf Group rises 16.8% » 12:00
01/28/20
01/28
12:00
01/28/20
12:00
LEAF

Leaf Group

$3.63 /

+0.53 (+17.10%)

Leaf Group is up 16.8%,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Delphi Technologies rises 59.9% » 12:00
01/28/20
01/28
12:00
01/28/20
12:00
DLPH

Delphi Technologies

$15.69 /

+5.895 (+60.21%)

Delphi Technologies is up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Treasury's $26 B 52-week bill offering garnered solid sponsorship » 11:55
01/28/20
01/28
11:55
01/28/20
11:55

Treasury's $26 B…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Stephens healthcare analysts to hold an analyst/industry conference call » 11:55
01/28/20
01/28
11:55
01/28/20
11:55

Healthcare Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Lockheed Martin says happy with current portfolio, has 'firepower' to pursue M&A  11:52
01/28/20
01/28
11:52
01/28/20
11:52
LMT

Lockheed Martin

$434.35 /

+2.04 (+0.47%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
LVMH to propose 13% increase in dividend » 11:51
01/28/20
01/28
11:51
01/28/20
11:51
LVMUY

LVMH

$0.00 /

+ (+0.00%)

At the Annual General…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Facebook's Zuckerberg provides update on privacy changes, says OFA now available » 11:51
01/28/20
01/28
11:51
01/28/20
11:51
FB

Facebook

$217.64 /

+2.79 (+1.30%)

Facebook's CEO Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
LVMH says 'cautiously confident for 2020' » 11:51
01/28/20
01/28
11:51
01/28/20
11:51
LVMUY

LVMH

$0.00 /

+ (+0.00%)

LVMH Moet Hennessy Louis…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Nintendo says Pokemon Home to launch in February 2020 » 11:50
01/28/20
01/28
11:50
01/28/20
11:50
NTDOY

Nintendo

$0.00 /

+ (+0.00%)

The Pokemon Company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
U.S. equities have extended higher » 11:50
01/28/20
01/28
11:50
01/28/20
11:50

U.S. equities have…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Earnings
LVMH reports Q4 revenue up 12% from last year » 11:49
01/28/20
01/28
11:49
01/28/20
11:49
LVMUY

LVMH

$0.00 /

+ (+0.00%)

LVMH Moet Hennessy Louis…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
52-Week Bill Auction Bid/Cover data reported » 11:42
01/28/20
01/28
11:42
01/28/20
11:42

52-Week Bill Auction…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
52-Week Bill Auction Total Amount data reported » 11:42
01/28/20
01/28
11:42
01/28/20
11:42

52-Week Bill Auction…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
2-Yr FRN Note Auction Bid/Cover data reported » 11:42
01/28/20
01/28
11:42
01/28/20
11:42

2-Yr FRN Note Auction…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.